Clinico-biological characteristics of patients with myelofibrosis: an analysis of 1,000 cases from the Spanish Registry of MyelofibrosisIrene Pastor‐Galán, Francisco Cervantes, Manuel Pérez‐Encinas et al.|Medicina Clínica (English Edition)|2020Cited by 12
Características clínico-biológicas de los pacientes con mielofibrosis: un análisis de 1.000 casos del Registro Español de MielofibrosisIrene Pastor‐Galán, Francisco Cervantes, Juan Carlos Hernández‐Boluda et al.|Medicina Clínica|2020Cited by 5
Mutational profile and cardiovascular risk factors impact prognosis in triple-negative essential thrombocythemiaGonzalo Carreño‐Tarragona, On behalf of the MPN Spanish Group (GEMFIN), Rodrigo Gil-Manso et al.|Leukemia|2026Cited by 0
Survival outcomes and treatment patterns in myelofibrosis in the <scp>JAK</scp> inhibitor eraJuan Carlos Hernández‐Boluda, the Spanish MPN Group (GEMFIN), Eduardo Arellano‐Rodrigo et al.|British Journal of Haematology|2026Cited by 0